These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6773242)

  • 1. What is the importance of the 'small pool concept' in the preparation of fraciton I and cryoprecipitates for the prevention of post-transfusion hepatitis?
    Vox Sang; 1980 Feb; 38(2):106-19. PubMed ID: 6773242
    [No Abstract]   [Full Text] [Related]  

  • 2. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

  • 3. Post-transfusion hepatits following the use of prothrombin complex concentrates.
    Roberts HR; Blatt PM
    Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remarks on the problem of Australia antigen as an etiologic factor in the outbreak of viral hepatitis].
    Drews J; Sachs V; Waldvogel B
    Dtsch Med Wochenschr; 1971 Nov; 96(48):1893-4. PubMed ID: 5119935
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transfusion hepatitis and inoculation hepatitis in the laboratory].
    Stampfli K
    Med Lab (Stuttg); 1969 Aug; 22(8):178-86. PubMed ID: 5351057
    [No Abstract]   [Full Text] [Related]  

  • 7. Common problems in blood transfusion.
    Nour-Eldin F
    Practitioner; 1976 Jan; 216(1291):64-72. PubMed ID: 772656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion hepatitis and its prevention].
    Creutzfeldt W
    Internist (Berl); 1966 Jan; 7(1):1-8. PubMed ID: 4861682
    [No Abstract]   [Full Text] [Related]  

  • 9. [The risk of hepatitis when using blood and blood products].
    Espmark A
    Lakartidningen; 1972 Dec; 69():Suppl 4:72-5. PubMed ID: 4656853
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transfusion hepatitis.
    Allen JG
    Calif Med; 1971 Apr; 114(4):67. PubMed ID: 5551310
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enzyme prevention of post-transfusion hepatitis].
    Mazhinskaia VP
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):58-60. PubMed ID: 5514434
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of the probability of post transfusion hepatitis in hemophilia treatment.
    Davis CE; Grizzle JE; Bryan JA
    Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517
    [No Abstract]   [Full Text] [Related]  

  • 13. [New viewpoints in the prevention of transfusion-induced serum hepatitis (Au-SH-Antigen)].
    Pesendorfer F; Krassnitzky O
    Wien Klin Wochenschr; 1971 Aug; 83(31):576-8. PubMed ID: 5566294
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B vaccination of blood donors--a cost-benefit analysis.
    Gesemann M; Gentner P; Scheiermann N
    Beitr Infusionsther Transfusionsmed; 1994; 32():110-2. PubMed ID: 9422105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transfusion hepatitis: a continuing problem.
    Miller DJ
    Conn Med; 1979 Apr; 43(4):212-4. PubMed ID: 219987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of prevention of post-transfusion type B hepatitis].
    Golosova TV
    Probl Gematol Pereliv Krovi; 1975 Apr; 20(4):9-16. PubMed ID: 1228774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Au-SH-antigen and hepatitis].
    Dtsch Med Wochenschr; 1970 Aug; 95(32):1665. PubMed ID: 5433410
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transfusion-hepatitis, the problem in the field of blood transfusion].
    Krebs HJ
    Schweiz Rundsch Med Prax; 1973 Sep; 62(36):1099-104. PubMed ID: 4728429
    [No Abstract]   [Full Text] [Related]  

  • 20. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
    Singh B; Verma M; Verma K
    Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.